The rise net profit was aided by strong performance of US, Europe, emerging markets and active pharmaceutical ingredients business. Favorable foreign exchange too added to the profit.from Moneycontrol Business News http://bit.ly/2BomjsQ
Thursday, February 7, 2019
Aurobindo Pharma Q3 FY19 net profit zooms 19.7% to Rs 712.2 crore, beats analysts#39; estimates
The rise net profit was aided by strong performance of US, Europe, emerging markets and active pharmaceutical ingredients business. Favorable foreign exchange too added to the profit.from Moneycontrol Business News http://bit.ly/2BomjsQ
No comments:
Post a Comment